Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Martin J Ryll und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Pulmonary Embolism, Critical Illness, APACHE, Intensive Care Units. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary embolism (PE) is a feared complication in the ICU, significantly impacting morbidity and mortality of the patients affected.Herein, we assess the use of the Acute Physiology and Chronic Health Evaluation-IV (APACHE-IV) and PE-specific risk scores to predictmortality among intensive care unit (ICU) patients who developed secondary PE. This retrospective cohort study used information from 208 United States critical care units recorded in the eICU Collaborative Research Database during 2014 and 2015. We calculated APACHE-IV, Pulmonary Embolism Severity Index (PESI), simplified PESI (sPESI), and ICU-sPESI scores and compared their predicting performance using the area under the receiver operating characteristic (AUROC) curve. Of 812 patients included in our study, 150 died (mortality, 18.5% [95% CI, 15.8%-21.1%]). Compared to survivors, non-survivors had higher APACHE-IV (86 vs 52, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
- Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Zitieren
APA
Ryll, M. J., Weingarten, T. N., Schroeder, D. R., & Sprung, J. (2024). Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10202
Vancouver
Ryll MJ, Weingarten TN, Schroeder DR, Sprung J. Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10202
BibTeX
@article{Ryll2024,
author = {Ryll, Martin J and Weingarten, Toby N and Schroeder, Darrel R and Sprung, Juraj},
title = {Validity of mortality risk prediction scores in critically ill patients with secondary pulmonary embolism},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10202}
}
EUVIMED